NasdaqGM:FOLDBiotechs
Assessing Amicus Therapeutics (FOLD) After Strong One Year Share Price Performance
If you are wondering whether Amicus Therapeutics at around US$14.37 is attractively priced or already reflecting a lot of optimism, you are in the right place to focus on what the numbers are actually saying about value.
The stock's return profile, with 0.3% over the last 7 days, 0.5% over 30 days, 0.7% year to date and 61.6% over 1 year, suggests the market has been reassessing the company over different time frames.
Recent news around Amicus Therapeutics has continued to center on its role...